Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Endothelial function: ready for prime time?

Subodh Verma¹, Paul E Szmitko, Todd J Anderson

¹Division of Cardiac Surgery, University of Toronto, Toronto, Canada. Subodh.Verma@Sympatico.ca

The Canadian Journal of Cardiology

|November 27, 2004

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Glucagon-Like Peptide 1 Receptor Agonists and Heart Failure: The Need for Further Evidence Generation and Practice Guidelines Optimization.

Circulation·2020

Same author

Outcomes of abdominal aortic aneurysm repair among patients with rheumatoid arthritis.

Journal of vascular surgery·2020

Same author

Generalizability of Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial in patients with a history of coronary artery bypass graft surgery.

Current opinion in cardiology·2020

Same author

Effect of Dapagliflozin on Outpatient Worsening of Patients With Heart Failure and Reduced Ejection Fraction: A Prespecified Analysis of DAPA-HF.

Circulation·2020

Same author

Apelin increases atrial conduction velocity, refractoriness, and prevents inducibility of atrial fibrillation.

JCI insight·2020

Same author

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.

The New England journal of medicine·2020

Endothelial dysfunction, a key factor in atherosclerosis, can be detected through function testing. This review explores endothelial function testing as a biomarker for cardiovascular disease risk.

Area of Science:

Cardiovascular Science
Vascular Biology
Biomarker Discovery

Background:

The endothelium, strategically positioned in blood vessels, senses hemodynamic forces and signals.
It releases autocrine and paracrine substances to maintain vascular homeostasis.
Disruption leads to endothelial cell dysfunction, promoting vasoconstriction, inflammation, and atherosclerosis.

Purpose of the Study:

To review current methods for assessing endothelial function.
To explore the utility of endothelial function as a biomarker for atherosclerosis.
To discuss the prognostic value and clinical applications of endothelial function testing.

Main Methods:

Review of current literature on endothelial function assessment modalities.
Analysis of the role of endothelial function in atherosclerosis development.

Related Experiment Videos

Evaluation of prognostic relevance and clinical utility.

Main Results:

Endothelial dysfunction is a critical early event in atherosclerosis.
Endothelial function testing shows promise as a biomarker for atherosclerotic disease.
Assessment of endothelial function has prognostic implications and clinical relevance.

Conclusions:

Endothelial function testing is a valuable tool for assessing atherosclerotic disease risk.
Understanding endothelial function is crucial for managing cardiovascular health.
Further research can refine clinical applications of endothelial function assessment.